Serotonergic effects of smoking are independent from the human serotonin transporter gene promoter polymorphism: Evidence from auditory cortical stimulus processing

Pharmacopsychiatry

Volumn 38, Issue 4, 2005, Pages 158-160

  Gallinat, Jürgen ^a   Kunz, D ^a   Lang, U E ^a   Kalus, P ^a   Juckel, G ^a   Eggers, J ^c   Mahlberg, R ^a   Staedtgen, M ^a   Wernicke, C ^a   Rommelspacher, H ^a   Smolka, M N ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^c Clinic for Neurology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN;

ADULT; ARTICLE; AUDITORY CORTEX; AUDITORY STIMULATION; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; EVOKED AUDITORY RESPONSE; FEMALE; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; PROMOTER REGION; SEROTONINERGIC SYSTEM;

ACOUSTIC STIMULATION; ADULT; AUDITORY CORTEX; AUDITORY PERCEPTION; DNA; EVOKED POTENTIALS, AUDITORY; FEMALE; GENOTYPE; HUMANS; LOUDNESS PERCEPTION; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SMOKING;

EID: 23044509661     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-871237     Document Type: Article

References (22)

1. Cheeta S, Irvine EE, Kenny PJ, File SE. The dorsal raphe nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses. Psychopharmacology 2001; 155: 78-85
2. Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G, Kuss HJ et al. The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl) 2000; 148: 404-411
3. Gallinat J, Senkowski D, Wernicke C, Juckel G, Becker I, Sander T et al. Allelic Variants of the Functional Promoter Polymorphism of the Human Serotonin Transporter Gene is Associated with Auditory Cortical Stimulus Processing. Neuropsychopharmacology 2003; 28: 530-532
4. Classman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet 2001; 357: 1929-1932
5. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 1999; 88: 83-87
6. Haro R, Drucker-Colin R. A two-year study on the effects of nicotine and its withdrawal on mood and sleep. Pharmacopsychiatry 2004; 37: 221-227
7. Heinz A, Jones DW, Bissette G, Hommer D, Ragan P, Knable M et al. Relationship between cortisol and serotonin metabolites and transporters in alcoholism. Pharmacopsychiatry 2002; 35: 127-134
8. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 2000; 47: 643-649
9. Huffman BJ. Expression cloning of a serotonin transporter: a new way to study antidepressant drugs. Pharmacopsychiatry 1994; 27: 16-22
10. Ishikawa H, Ohtsuki T, Ishiguro H, Yamakawa-Kobayashi K, Endo K, Lin YL et al. Association between serotonin transporter gene polymorphism and smoking among Japanese males. Cancer Epidemiol Biomarkers Prev 1999; 8: 831-833
11. Juckel G, Hegerl U, Molnar M, Csepe V, Karmos G. Auditory evoked potentials reflect serotonergic neuronal activity - a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 1999; 21: 710-716
12. Juckel G, Mavrogiorgou P, Bredemeier S, Gallinat J, Frodl T, Schulz C et al. Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders - a retrospective study. Pharmacopsychiatry 2004; 37: 46-51
13. Lang UE, Hellweg R, Gallinat J. Association of BDNF serum concentrations with central serotonergic activity: Evidence from auditory signal processing. Neuropsychopharmacology, 2005; in press
14. Lerman C, Shields PG, Audrain J, Main D, Cobb B, Boyd NR et al. The role of the serotonin transporter gene in cigarette smoking. Cancer Epidemiol Biomarkers Prev 1998; 7: 253-255
15. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531
16. Miller MM, Abplanalp H, Goto R. Genotyping chickens for the B-G sub-region of the major histocompatibility complex using restriction fragment length polymorphisms. Immunogenetics 1988; 28: 374-379
17. Miyata G, Meguid MM, Fetissov SO, Torelli GF, Kim HJ. Nicotine's effect on hypothalamic neurotransmitters and appetite regulation. Surgery 1999; 126: 255-263
18. Murphy JM, Horton NJ, Monson RR, Laird NM, Sobol AM, Leighton AH. Cigarette smoking in relation to depression: historical trends from the Stirling County Study. Am J Psychiatry 2003; 160: 1663-1669
19. Racke K, Schworer H, Simson G. Effects of cigarette smoking or ingestion of nicotine on platelet 5-hydroxytryptamine (5-HT) levels in smokers and nonsmokers. Clin Investig 1992; 70: 201-204
20. Sander T, Harms H, Dufeu P, Kuhn S, Hoehe M, Lesch KP et al. Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder. Biol Psychiatry 1998; 43: 908-912
21. Sparrow D, O'Connor GT, Young JB, Rosner B, Weiss ST. Relationship of urinary serotonin excretion to cigarette smoking and respiratory symptoms. The Normative Aging Study. Chest 1992; 101: 976-980
22. Staley JK, Krishnan-Sarin S, Zoghbi S, Tamagnan G, Fujita M, Seibyl JP et al. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse 2001; 41: 275-284